Barclays analyst Luke Sergott maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $24.00. The company’s...
we did hear some things towards the end of the quarter of service providers just with having recession fears in general, wanting to carry less inventory overall. So I think it’s more activity driven than stock driven.
Current Price $48.02 NYSE: BHC Bausch Health Companies Market Cap $3B Current Price $8.26 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. ...
Total operating expenses for 2022 were $564 million compared to $468.7 million for 2021. The increase in operating expenses was primarily driven by an increase in personnel expenses, including stock-based compensation expense, and higher costs for facilities and information technology to support operati...